About
Chris Weyrer's physics/neurobiology background and Harvard gene therapy work give him a mechanistic edge in biology; as Acting CBO he guided Protego's $130M Series B into pivotal AL amyloidosis studies.
Contact· self-published, not guessed
Invests in
BiotechHealthtech
Experience
- SonoTheraBoard Observercurrent2026 — presentMetropolregion San Francisco Bay Area
- Protego BiopharmaChief Business Officer and Board Membercurrent2024 — presentSan Diego, California, United States
- Vida Ventures, LLCVenture Capital - Life Sciencecurrent2022 — presentLos Angeles Metropolitan Area
- LB Pharmaceuticals Inc.Board Observer, SAB Advisor and Operations2023 — 2025New York, United States
- Capstan TherapeuticsBoard Observer2023 — 2024
- Kyverna TherapeuticsBoard Observer2023 — 2024
- Boston Consulting Group (BCG)Project Leader2022Santa Monica, California, United States
- Boston Consulting Group (BCG)Consultant2020 — 2022Los Angeles, California, United States
- Harvard Medical SchoolAlice & Joseph Brooks Research Fellow in Neuroscience2018 — 2021Greater Boston Area
- Harvard Medical SchoolJoint PhD Student & Research Fellow2015 — 2018Greater Boston Area
- University of CambridgeJoint PhD Student2014 — 2018Cambridge, United Kingdom
- The Boston Consulting Group (BCG)Bridge to BCG2017Greater Boston Area
- Bain & CompanyBain Advance into Consulting2017Greater Boston Area
- Point72NDA-protected healthcare project for Point 72 Asset Management2016Greater New York City Area
- McKinsey & CompanyMcKinsey MD Contact2015San Francisco Bay Area
- Salk Institute for Biological StudiesShort-term Research Fellow2012Großraum San Diego und Umgebung
- Max F. Perutz LaboratoriesTraining in Molecular Biology, Genetics and Biochemistry2011Wien
- Medical University of ViennaState Licensed Medical Doctor, MD2011
- University of MauritiusMedicine Exchange Semester - Medical Clerkships - Clinical Rotations2010Mauritius
Skills & more
Neuroscience3Medicine1Physics2Life Sciences2Biotechnology1Start-upsMedical ImagingEntrepreneurshipMedical Device R&DConsultingBiotechnology IndustryHealthcare Consulting1
+8 more
Start-up ConsultingStart-up VenturesManagement ConsultingNeuroeconomicsOptoelectronicsNeurologyPsychiatryMedical DevicesLanguages Deutsch · English · Español · Français · Latin
From Chris's professional profile.
Colleagues at Vida Ventures
Alessandro Giacometti
Vice President, Head of Investor Relations at Vida Ventures
Alex Loftis
Principal at Vida Ventures
Alex Mejia
Executive Services Manager at Vida Ventures
Alex Shen
Director of Operations at Vida Ventures
Andy Kadlec
Senior Associate at Vida Ventures
Anita Keenan
Executive Assistant at Vida Ventures
Arie Belldegrun
Founder and Senior Managing Director at Vida Ventures
Brian Goodman
Managing Director at Vida Ventures
Frequently asked questions
- Who is Chris Weyrer?
- Chris Weyrer's physics/neurobiology background and Harvard gene therapy work give him a mechanistic edge in biology; as Acting CBO he guided Protego's $130M Series B into pivotal AL amyloidosis studies.
- Where does Chris Weyrer work?
- Chris Weyrer is Principal at Vida Ventures.
- What does Chris Weyrer invest in?
- Chris Weyrer invests in Biotech, Healthtech.
- Where did Chris Weyrer go to school?
- Chris Weyrer studied at Harvard Medical School (Doctor of Philosophy (Ph.D.), Neuroscience); University of Cambridge (Doctor of Philosophy (Ph.D.), Neurobiology and Neurosciences); Medical University of Vienna (Doctor of Medicine (M.D.), Medicine).
Same school
Also attended Harvard Medical School181
Niko BonatsosVerdict Capital founder and pre-consensus investor formerly at General CatalystAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital
.png)
+ 175 more
Also attended University of Cambridge1,186
Stewart ButterfieldCo-founder of Slack and FlickrDemis HassabisCo-founder & CEO of Google DeepMindNiko BonatsosVerdict Capital founder and pre-consensus investor formerly at General CatalystGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesLeah von SiemensPartner at Manta Ray Ventures
+ 1,180 more
Also attended Medical University of Vienna2
Also attended WU (Vienna University of Economics and Business)210
Patrick NorrisGeneral Partner at Notion CapitalFerlyn TanInvestor, Orbit at Openspace VenturesDebbie IrwinExecutive Director at Lighthouse Network Ventures LlcKevin GroveVenture Partner at Versant VenturesJanelle GoulardPartner at Pangaea Ventures Us Inc.Alex LoftisPrincipal at Vida Ventures
+ 204 more
Shared employers
Also worked at LB Pharmaceuticals Inc.1
Also worked at Boston Consulting Group (BCG)1,185
David SzeAdvisory Partner at GreylockDave MunichielloInvestor at GV (Google Ventures)Massimo PrelzInvestor at DN CapitalRasmus AreskougInvestor at DN CapitalRiccardo MontiOperating Advisor at P101 VenturesAntonio TurroniOperating Advisor at P101 Ventures
+ 1,179 more
Also worked at Harvard Medical School202
Logan HilleLife Sciences Analyst at CincyTechAnkit GuptaGeneral Partner at Y CombinatorDavid MollerInvestor at Third Rock VenturesJulie YangInvestor at Third Rock VenturesTracy WilliamsInvestor at Third Rock VenturesSamuel ArbesmanVenture Partner at Lux Capital
+ 196 more
Also worked at McKinsey & Company1,973
Elad GilSolo general partner investing through Gil CapitalJim BreyerFounder & CEO of Breyer CapitalAnn Miura-KoCo-founding Partner at FloodgateJeremy LiewPartner at Lightspeed Venture PartnersMike SpeiserManaging Director at Sutter Hill VenturesJeremy LevinePartner at Bessemer Venture Partners
+ 1,967 more